文献速递药物不良反应与药物警戒

手性特征与因安全性撤药关联的比较分析

The association of chiral characteristic with drug withdrawal due to safety: A comparative analysis.
PubMed 文献 · Br J Clin Pharmacol · 2022-08-26

该研究比较了因安全性问题撤市的药物(n=391)与所有可用小分子药物(n=1633)的手性状态,发现纯对映体较非手性药物(HR 2.1,95%CI 1.6-2.7)和手性混合物(HR 2.6,95%CI 1.9-3.5)撤药率更低,且纯对映体平均生存时间最长(62.4±0.8年)。

要点

  • 纯对映体撤药风险低于非手性药物和手性混合物。
  • 纯对映体平均生存时间最长,手性混合物最短。
  • 神经系统药物中纯对映体撤药率低于手性混合物。

核心结论

  • 纯对映体相比手性混合物和非手性药物撤药可能性更低,在特定上市年代及肝毒性、心血管毒性不良反应中更显著。

研究设计与样本

  • 检索因安全性问题撤市药物(n=391)与所有可用小分子药物(n=1633),按非手性、手性混合物或纯对映体分类比较撤药率与平均生存时间。

主要发现

  • 非手性药物撤药风险比纯对映体高(HR 2.1,95%CI 1.6-2.7),手性混合物更高(HR 2.6,95%CI 1.9-3.5)。
  • 纯对映体平均生存时间62.4±0.8年,非手性药物55.4±0.9年(P<.01),手性混合物52.4±1.4年(P<.01)。
  • 1941年前、1961-1980年及1981-2000年上市的纯对映体生存率高于手性混合物(分别P=.02、P<.001、P<.001)。
  • 神经系统药物中纯对映体撤药率18.2%,低于手性混合物的35.1%(P=.02)。
  • 纯对映体在肝毒性(P<.01)和心血管不良反应(P<.01)中撤药率低于手性混合物。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Chirality of drugs might be associated with safety issues through pharmacokinetic or pharmacodynamic variations, interactions, or direct toxicological responses. We aimed to compare chiral status of the available drugs to that of drugs withdrawn due to adverse drug reactions (ADRs). METHODS: We searched the literature regarding withdrawn drugs due to safety-related issues (n = 391) to compare them with all available small-molecule drugs (n = 1633). We examined their chiral status and assigned as achiral compound, chiral mixture or pure enantiomer. We compared the mean survival (i.e., nonwithdrawal) time and withdrawal rates of drugs by their chirality, with further stratification by the launch year, ATC-1 (Anatomical Therapeutic Chemical) level and ADR. RESULTS: We identified higher withdrawal rate in achiral drugs (hazard ratio 2.1, 95% CI: 1.6-2.7) and chiral mixtures (hazard ratio 2.6, 95% CI: 1.9-3.5) compared to that in pure enantiomers. Pure enantiomers had the longest mean survival time (62.4 ± 0.8 years), followed by achiral drugs (55.4 ± 0.9 years, P < .01) and chiral mixtures (52.4 ± 1.4 years, P < .01). Pure enantiomers had higher survival rates than chiral mixtures if launched before 1941 (P = .02), in 1961-1980 (P < .001) or 1981-2000 (P < .001). Pure enantiomers had lower withdrawal rate (18.2%) vs. chiral mixtures (35.1%, P = .02) in nervous system drugs. Pure enantiomers had lower withdrawal rate than chiral mixtures in hepatotoxic (P < .01) and cardiovascular ADRs (P < .01). CONCLUSION: Our study showed lower likelihood of withdrawal for pure enantiomers compared to that in chiral mixtures and achiral drugs, which was more remarkable for those launched in certain time periods and several ADRs, including hepatotoxicity and cardiovascular toxicity.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Aydin V, Bahar A, Vizdiklar C, et al. The association of chiral characteristic with drug withdrawal due to safety: A comparative analysis. Br J Clin Pharmacol. 2022. PMID: 35942905. doi:10.1111/bcp.15486

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。